Curis, Inc. (CRIS) vs Cellyan Biotechnology Co., Ltd (HKPD)
A side-by-side comparison of Curis, Inc. and Cellyan Biotechnology Co., Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRIS
Curis, Inc.
$0.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
HKPD
Cellyan Biotechnology Co., Ltd
$0.10HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CRIS vs HKPD
growth of $100 · dividends reinvested · last 2yCRIS -98.9% (-89.7%/yr)HKPD -96.3% (-80.8%/yr)HKPD compounded faster over this window
CRIS HKPD
CRIS vs HKPD: by the numbers
- •CRIS is the larger company ($1M vs $1M market cap).
- •Both run net losses; HKPD's is the smaller (-8.46% vs -490.33% net margin).
Metrics side by side
Valuation
| Metric | CRIS | HKPD |
|---|---|---|
| P/S ratio | 0.34 | N/A |
| P/B ratio | 0.31 | 0.12 |
Profitability
| Metric | CRIS | HKPD |
|---|---|---|
| Gross margin | 99.28% | 10.32% |
| Operating margin | -348.43% | -7.41% |
| Net margin | -490.33% | -8.46% |
| ROE | -450.54% | -11.85% |
| ROIC | -567.17% | -9.45% |
Growth (annualized)
| Metric | CRIS | HKPD |
|---|---|---|
| Revenue CAGR (5Y) | -15.88% | N/A |
| Total return CAGR (5Y) | -81.06% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.